Evidence map›Paper›PMID 42424253›Full record

ArticlePLoS pathogens2026

Characterisation of the thermal and non-thermal stress conditions that activate the Plasmodium falciparum AP2-HS-dependent heat-shock response.

Neus Ràfols, Prince B Nyarko, Marc Chillarón-Adán, Elisabet Tintó-Font, Alfred Cortés

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neus RàfolsMalaria and Neglected Parasitic Diseases Programme, ISGlobal, Barcelona, Catalonia, Spain.
Prince B NyarkoMalaria and Neglected Parasitic Diseases Programme, ISGlobal, Barcelona, Catalonia, Spain.
Marc Chillarón-AdánMalaria and Neglected Parasitic Diseases Programme, ISGlobal, Barcelona, Catalonia, Spain.
Elisabet Tintó-FontMalaria and Neglected Parasitic Diseases Programme, ISGlobal, Barcelona, Catalonia, Spain.
Alfred CortésMalaria and Neglected Parasitic Diseases Programme, ISGlobal, Barcelona, Catalonia, Spain.ORCID 0000-0003-0730-6582

Funding

Agencia Estatal de InvestigaciónEuropean Regional Development FundISGlobal’s Program on the Molecular Mechanisms of MalariaSpanish Ministry of Science and Innovation (MCIN)
6 · The paper itself

Abstract

To preserve proteome homeostasis and survive at higher-than-optimal temperatures, organisms have evolved the conserved heat-shock (HS) response (HSR), characterised by increased expression of specific chaperone-encoding genes. In the human blood, malaria parasites are frequently exposed to elevated temperatures associated with host fever episodes. The protective HSR of Plasmodium falciparum, the parasite that produces the vast majority of malaria clinical cases and deaths, is regulated by the transcription factor AP2-HS. Here, we systematically investigated the conditions that trigger the AP2-HS-dependent HSR and found that even mild HS conditions that do not compromise parasite viability can activate this response. As in other organisms, activation of the HSR in P. falciparum is rapid, as it was observed after a HS of only 10 min. Dihydroartemisinin (DHA), a drug that produces general proteome damage, also triggered the HSR, indicating that activation of the malarial HSR is not restricted to thermal stress. The AP2-HS-dependent HSR can be activated in all asexual blood stages, with the exception of very young rings, but not in intermediate or mature gametocyte stages. Accordingly, these gametocyte stages are highly sensitive to HS. Since mature gametocytes are the only stage that can mediate human-to-mosquito transmission, these results suggest that malaria patients with high fever may become transiently non-infectious.

Indexed as

Heat-Shock ResponseMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsTranscription Factor AP-2ArtemisininsHot TemperatureHumansArtemisininsartenimolProtozoan ProteinsTranscription Factor AP-2

Identifiers

PMID42424253
PMCPMC13349141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.